$PLUR
Pluri Inc. Stock $plur

$plur Overview Financials Valuation SEC Filings Company Website

2015 Q3 Form 10-K Financial Statement

#000117891315002818 Filed on September 09, 2015

Income Statement

Concept	2015 Q3	2015 Q2	2015
Revenue	$100.0K	$90.00K	$379.0K
YoY Change	5.26%	0.0%	0.0%
Cost Of Revenue	$0.00	$0.00	$13.00K
YoY Change	-100.0%		18.18%
Gross Profit	$90.00K	$90.00K	$366.0K
YoY Change	-2.17%	0.0%	-0.54%
Gross Profit Margin	90.0%	100.0%	96.57%
Selling, General & Admin	$1.490M	$1.740M	$6.460M
YoY Change	-11.31%	-25.64%	-25.58%
% of Gross Profit	1655.56%	1933.33%	1765.03%
Research & Development			$23.42M
YoY Change			-6.1%
% of Gross Profit			6397.81%
Depreciation & Amortization	$500.0K	$570.0K	$2.074M
YoY Change	0.4%	18.75%	9.04%
% of Gross Profit	555.56%	633.33%	566.67%
Operating Expenses	$5.620M	$5.910M	$23.42M
YoY Change	-1.75%	-13.22%	-6.1%
Operating Profit	-$5.530M	-$5.820M	-$25.27M
YoY Change	-1.65%	-13.39%	-9.27%
Interest Expense	$290.0K	$440.0K	$630.0K
YoY Change	45.0%	-15.38%	-33.68%
% of Operating Profit
Other Income/Expense, Net	-$640.0K	$80.00K	$590.0K
YoY Change	122.22%		-35.73%
Pretax Income	-$5.880M	-$5.300M	-$24.68M
YoY Change	-0.51%	-14.52%	-8.35%
Income Tax
% Of Pretax Income
Net Earnings	-$5.880M	-$5.300M	-$24.68M
YoY Change	-0.52%	-14.52%	-8.37%
Net Earnings / Revenue	-5880.0%	-5888.89%	-6511.08%
Basic Earnings Per Share
Diluted Earnings Per Share	-$0.75	-$0.74	-$3.511M
COMMON SHARES
Basic Shares Outstanding	79.11M shares	71.25M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2015 Q3	2015 Q2	2015
SHORT-TERM ASSETS
Cash & Short-Term Investments	$46.69M	$52.04M	$52.04M
YoY Change	1.39%	-3.47%	-3.47%
Cash & Equivalents	$10.81M	$22.63M	$22.63M
Short-Term Investments	$35.88M	$29.42M	$29.42M
Other Short-Term Assets	$1.700M	$2.058M	$2.320M
YoY Change	141.48%	127.4%	-60.14%
Inventory
Prepaid Expenses		$919.0K
Receivables	$420.0K	$1.691M	$1.740M
Other Receivables	$0.00	$621.0K	$770.0K
Total Short-Term Assets	$48.81M	$56.87M	$56.87M
YoY Change	-6.66%	-8.26%	-8.26%
LONG-TERM ASSETS
Property, Plant & Equipment	$10.40M	$10.17M	$10.17M
YoY Change	-1.34%	-6.01%	-6.01%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$340.0K	$360.0K	$360.0K
YoY Change	17.24%	20.0%	20.0%
Other Assets	$760.0K	$1.000K	$750.0K
YoY Change	37900.0%	-87.5%	-17.58%
Total Long-Term Assets	$11.50M	$11.29M	$11.29M
YoY Change	-0.33%	-6.22%	-6.15%
TOTAL ASSETS
Total Short-Term Assets	$48.81M	$56.87M	$56.87M
Total Long-Term Assets	$11.50M	$11.29M	$11.29M
Total Assets	$60.31M	$68.16M	$68.16M
YoY Change	-5.51%	-7.93%	-7.92%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.500M	$3.268M	$3.270M
YoY Change	-38.04%	-5.69%	-5.76%
Accrued Expenses	$1.010M	$910.0K	$2.350M
YoY Change	0.7%	-0.55%	1.73%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$4.240M	$6.183M	$6.180M
YoY Change	-29.16%	-16.41%	-16.49%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$3.720M	$502.0K	$3.830M
YoY Change	557.24%	-14.63%	-14.89%
Total Long-Term Liabilities	$3.720M	$3.829M	$3.830M
YoY Change	-10.36%	-14.97%	-14.89%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.240M	$6.183M	$6.180M
Total Long-Term Liabilities	$3.720M	$3.829M	$3.830M
Total Liabilities	$7.960M	$10.01M	$10.01M
YoY Change	-21.46%	-15.87%	-15.88%
SHAREHOLDERS EQUITY
Retained Earnings		-$138.5M
YoY Change		21.68%
Common Stock		$1.000K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$52.35M	$58.14M	$58.14M
YoY Change
Total Liabilities & Shareholders Equity	$60.31M	$68.16M	$68.16M
YoY Change	-5.51%	-7.93%	-7.92%

Cashflow Statement

Concept	2015 Q3	2015 Q2	2015
OPERATING ACTIVITIES
Net Income	-$5.880M	-$5.300M	-$24.68M
YoY Change	-0.52%	-14.52%	-8.37%
Depreciation, Depletion And Amortization	$500.0K	$570.0K	$2.074M
YoY Change	0.4%	18.75%	9.04%
Cash From Operating Activities	-$3.770M	-$5.020M	-$20.61M
YoY Change	8.96%	-6.17%	7.79%
INVESTING ACTIVITIES
Capital Expenditures	$1.110M	$190.0K	$831.0K
YoY Change	309.59%	46.15%	-47.17%
Acquisitions
YoY Change
Other Investing Activities	-$7.750M	$3.060M	$22.37M
YoY Change	-261.8%	-46.78%	528.37%
Cash From Investing Activities	-$8.860M	$2.870M	$21.54M
YoY Change	-296.02%	-48.75%	987.88%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$16.91M
YoY Change			58.91%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	810.0K	15.83M	17.20M
YoY Change	636.36%	2538.33%	36.29%
NET CHANGE
Cash From Operating Activities	-3.770M	-5.020M	-20.61M
Cash From Investing Activities	-8.860M	2.870M	21.54M
Cash From Financing Activities	810.0K	15.83M	17.20M
Net Change In Cash	-11.82M	13.68M	18.13M
YoY Change	-1110.26%	1509.41%	-501.11%
FREE CASH FLOW
Cash From Operating Activities	-$3.770M	-$5.020M	-$20.61M
Capital Expenditures	$1.110M	$190.0K	$831.0K
Free Cash Flow	-$4.880M	-$5.210M	-$21.44M
YoY Change	30.8%	-4.93%	3.61%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2015Q2	us-gaap	Assets Assets	68155000	USD
CY2014Q2	us-gaap	Assets Assets	74023000	USD
CY2015Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	22626000	USD
CY2014Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4493000	USD
CY2015Q2	us-gaap	Short Term Investments ShortTermInvestments	7167000	USD
CY2014Q2	us-gaap	Short Term Investments ShortTermInvestments	19451000	USD
CY2015Q2	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	1076000	USD
CY2014Q2	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	4914000	USD
CY2015Q2	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	22250000	USD
CY2014Q2	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	29961000	USD
CY2015Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1691000	USD
CY2014Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2263000	USD
CY2015Q2	us-gaap	Other Assets Current OtherAssetsCurrent	2058000	USD
CY2014Q2	us-gaap	Other Assets Current OtherAssetsCurrent	905000	USD
CY2015Q2	us-gaap	Assets Current AssetsCurrent	56868000	USD
CY2014Q2	us-gaap	Assets Current AssetsCurrent	61987000	USD
CY2015Q2	us-gaap	Long Term Investments LongTermInvestments	360000	USD
CY2014Q2	us-gaap	Long Term Investments LongTermInvestments	304000	USD
CY2015Q2	us-gaap	Defined Benefit Plan Assets For Plan Benefits Noncurrent DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent	753000	USD
CY2014Q2	us-gaap	Defined Benefit Plan Assets For Plan Benefits Noncurrent DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent	901000	USD
CY2015Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	10173000	USD
CY2014Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	10823000	USD
CY2015Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1000	USD
CY2014Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	8000	USD
CY2015Q2	us-gaap	Assets Noncurrent AssetsNoncurrent	11287000	USD
CY2014Q2	us-gaap	Assets Noncurrent AssetsNoncurrent	12036000	USD
CY2015Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	3268000	USD
CY2014Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	3465000	USD
CY2015Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	910000	USD
CY2014Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	915000	USD
CY2015Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	379000	USD
CY2014Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	379000	USD
CY2015Q2	us-gaap	Customer Advances Current CustomerAdvancesCurrent	93000	USD
CY2014Q2	us-gaap	Customer Advances Current CustomerAdvancesCurrent	247000	USD
CY2015Q2	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	1533000	USD
CY2014Q2	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	2391000	USD
CY2015Q2	us-gaap	Liabilities Current LiabilitiesCurrent	6183000	USD
CY2014Q2	us-gaap	Liabilities Current LiabilitiesCurrent	7397000	USD
CY2014Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	4503000	USD
CY2014	us-gaap	Revenues Revenues	379000	USD
CY2013	us-gaap	Revenues Revenues	679000	USD
CY2014	us-gaap	Cost Of Revenue CostOfRevenue	11000	USD
CY2015	us-gaap	Gross Profit GrossProfit	366000	USD
CY2014	us-gaap	Gross Profit GrossProfit	368000	USD
CY2013	us-gaap	Gross Profit GrossProfit	659000	USD
CY2013	psti	Government And Third Party Grants Received GovernmentAndThirdPartyGrantsReceived	2673000	USD
CY2015	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	23416000	USD
CY2015Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2013	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	19906000	USD
CY2015	psti	Government And Third Party Grants Received GovernmentAndThirdPartyGrantsReceived	4243000	USD
CY2015Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	78771905	shares
CY2014	psti	Research And Development Expenses Net ResearchAndDevelopmentExpensesNet	19542000	USD
CY2015	psti	Research And Development Expenses Net ResearchAndDevelopmentExpensesNet	19173000	USD
CY2014Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	68601452	shares
CY2015	us-gaap	Revenues Revenues	379000	USD
CY2015	us-gaap	Cost Of Revenue CostOfRevenue	13000	USD
CY2014	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	24938000	USD
CY2014	psti	Government And Third Party Grants Received GovernmentAndThirdPartyGrantsReceived	5396000	USD
CY2013	psti	Research And Development Expenses Net ResearchAndDevelopmentExpensesNet	17233000	USD
CY2015	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6460000	USD
CY2014	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	8676000	USD
CY2013	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5649000	USD
CY2015	us-gaap	Operating Income Loss OperatingIncomeLoss	-25267000	USD
CY2014	us-gaap	Operating Income Loss OperatingIncomeLoss	-27850000	USD
CY2015Q2	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	2468000	USD
CY2014Q2	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	2847000	USD
CY2015	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	590000	USD
CY2014	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	918000	USD
CY2013	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1068000	USD
CY2015	us-gaap	Net Income Loss NetIncomeLoss	-24677000	USD
CY2013	us-gaap	Net Income Loss NetIncomeLoss	-21155000	USD
CY2015	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.35
CY2014	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.42
CY2013	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.38
CY2015	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	70284337	shares
CY2014	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	63514405	shares
CY2013	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	55481357	shares
CY2015Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-138511000	USD
CY2014Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-113834000	USD
CY2015Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	2140000	USD
CY2014Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	2959000	USD
CY2015Q2	us-gaap	Stockholders Equity StockholdersEquity	58143000	USD
CY2015Q2	us-gaap	Postemployment Benefits Liability Noncurrent PostemploymentBenefitsLiabilityNoncurrent	859000	USD
CY2014Q2	us-gaap	Postemployment Benefits Liability Noncurrent PostemploymentBenefitsLiabilityNoncurrent	1068000	USD
CY2015Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	502000	USD
CY2014Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	588000	USD
CY2015Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	3829000	USD
CY2015Q2	us-gaap	Common Stock Value CommonStockValue	1000	USD
CY2014Q2	us-gaap	Common Stock Value CommonStockValue		USD
CY2015Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	195303000	USD
CY2014Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	172998000	USD
CY2014Q2	us-gaap	Stockholders Equity StockholdersEquity	62123000	USD
CY2015Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	68155000	USD
CY2014Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	74023000	USD
CY2015Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2014Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2015Q2	us-gaap	Receivable From Shareholders Or Affiliates For Issuance Of Capital Stock ReceivableFromShareholdersOrAffiliatesForIssuanceOfCapitalStock	790000	USD
CY2014Q2	us-gaap	Receivable From Shareholders Or Affiliates For Issuance Of Capital Stock ReceivableFromShareholdersOrAffiliatesForIssuanceOfCapitalStock		USD
CY2015Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2014Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2014Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2015Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	78771905	shares
CY2014Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	68601452	shares
CY2013	us-gaap	Operating Income Loss OperatingIncomeLoss	-22223000	USD
CY2014	us-gaap	Net Income Loss NetIncomeLoss	-26932000	USD
CY2015	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	285000	USD
CY2014	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	-25000	USD
CY2013	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax		USD
CY2015	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-1132000	USD
CY2014	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	3404000	USD
CY2013	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	415000	USD
CY2015	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	-290000	USD
CY2014	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	727000	USD
CY2013	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	26000	USD
CY2015	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-25496000	USD
CY2014	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-24232000	USD
CY2013	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-20766000	USD
CY2012Q2	us-gaap	Stockholders Equity StockholdersEquity	37742000	USD
CY2013	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	34106000	USD
CY2013	psti	Stock Issued During Period Value Stock Options And Warrants Exercised StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised	176000	USD
CY2013	psti	Stock Issued During Period Value Stock Warrants Exercised StockIssuedDuringPeriodValueStockWarrantsExercised	2009000	USD
CY2013	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	2799000	USD
CY2013	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	1400000	USD
CY2013	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	389000	USD
CY2013Q2	us-gaap	Stockholders Equity StockholdersEquity	57466000	USD
CY2014	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	10644000	USD
CY2014	psti	Stock Issued During Period Value Stock Options And Warrants Exercised StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised	12000	USD
CY2014	psti	Stock Issued During Period Value Stock Warrants Exercised StockIssuedDuringPeriodValueStockWarrantsExercised	1968000	USD
CY2014	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	5851000	USD
CY2014	us-gaap	Stock Issued During Period Value Purchase Of Assets StockIssuedDuringPeriodValuePurchaseOfAssets	10414000	USD
CY2014	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	2700000	USD
CY2015	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	15800000	USD
CY2013	us-gaap	Cost Of Revenue CostOfRevenue	20000	USD
CY2015	psti	Stock Issued During Period Value Stock Options And Warrants Exercised StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised	11000	USD
CY2015	psti	Stock Issued During Period Value Stock Warrants Exercised StockIssuedDuringPeriodValueStockWarrantsExercised	276000	USD
CY2015	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	4052000	USD
CY2015	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	-290000	USD
CY2013	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment		USD
CY2015	psti	Stock Issued During Period Value Private Placement StockIssuedDuringPeriodValuePrivatePlacement	1114000	USD
CY2015	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	263000	USD
CY2015	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-819000	USD
CY2013	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	2694000	USD
CY2014	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	195000	USD
CY2015	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	1200000	USD
CY2015	us-gaap	Depreciation Depreciation	2074000	USD
CY2014	us-gaap	Depreciation Depreciation	1902000	USD
CY2013	us-gaap	Depreciation Depreciation	1033000	USD
CY2015	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-20000	USD
CY2014	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-85000	USD
CY2015	psti	Amortization Of Discount And Premium And Changes In Accrued Interest From Marketable Securities AmortizationOfDiscountAndPremiumAndChangesInAccruedInterestFromMarketableSecurities	213000	USD
CY2014	psti	Amortization Of Discount And Premium And Changes In Accrued Interest From Marketable Securities AmortizationOfDiscountAndPremiumAndChangesInAccruedInterestFromMarketableSecurities	1282000	USD
CY2013	psti	Amortization Of Discount And Premium And Changes In Accrued Interest From Marketable Securities AmortizationOfDiscountAndPremiumAndChangesInAccruedInterestFromMarketableSecurities	154000	USD
CY2014	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	727000	USD
CY2013	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	26000	USD
CY2015	us-gaap	Share Based Compensation ShareBasedCompensation	4052000	USD
CY2014	us-gaap	Share Based Compensation ShareBasedCompensation	5851000	USD
CY2013	us-gaap	Share Based Compensation ShareBasedCompensation	2799000	USD
CY2015	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-572000	USD
CY2014	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	1990000	USD
CY2013	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	70000	USD
CY2015	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	1129000	USD
CY2015	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-566000	USD
CY2014	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1257000	USD
CY2013	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1335000	USD
CY2015	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-949000	USD
CY2014	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	902000	USD
CY2013	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	1556000	USD
CY2015	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-379000	USD
CY2014	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-379000	USD
CY2013	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-679000	USD
CY2015	us-gaap	Increase Decrease In Customer Advances IncreaseDecreaseInCustomerAdvances	-154000	USD
CY2014	us-gaap	Increase Decrease In Customer Advances IncreaseDecreaseInCustomerAdvances	-146000	USD
CY2013	us-gaap	Increase Decrease In Customer Advances IncreaseDecreaseInCustomerAdvances	-1183000	USD
CY2015	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	-35000	USD
CY2014	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	36000	USD
CY2013	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	140000	USD
CY2015	psti	Linkage Differences And Interest On Short And Long Term Restricted Lease Deposit LinkageDifferencesAndInterestOnShortAndLongTermRestrictedLeaseDeposit	54000	USD
CY2014	psti	Linkage Differences And Interest On Short And Long Term Restricted Lease Deposit LinkageDifferencesAndInterestOnShortAndLongTermRestrictedLeaseDeposit	12000	USD
CY2013	psti	Linkage Differences And Interest On Short And Long Term Restricted Lease Deposit LinkageDifferencesAndInterestOnShortAndLongTermRestrictedLeaseDeposit	-30000	USD
CY2015	us-gaap	Increase Decrease In Pension And Postretirement Obligations IncreaseDecreaseInPensionAndPostretirementObligations	-61000	USD
CY2014	us-gaap	Increase Decrease In Pension And Postretirement Obligations IncreaseDecreaseInPensionAndPostretirementObligations	49000	USD
CY2013	us-gaap	Increase Decrease In Pension And Postretirement Obligations IncreaseDecreaseInPensionAndPostretirementObligations	-11000	USD
CY2015	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-20605000	USD
CY2014	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-19121000	USD
CY2013	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-16887000	USD
CY2014	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	251000	USD
CY2013	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	470000	USD
CY2015	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	831000	USD
CY2014	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1573000	USD
CY2013	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4309000	USD
CY2015	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	19000	USD
CY2014	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment		USD
CY2015	us-gaap	Payments For Proceeds From Short Term Investments PaymentsForProceedsFromShortTermInvestments	-16061000	USD
CY2014	us-gaap	Payments For Proceeds From Short Term Investments PaymentsForProceedsFromShortTermInvestments	-7421000	USD
CY2013	us-gaap	Payments For Proceeds From Short Term Investments PaymentsForProceedsFromShortTermInvestments	10202000	USD
CY2015	us-gaap	Payments For Proceeds From Longterm Investments PaymentsForProceedsFromLongtermInvestments	78000	USD
CY2014	us-gaap	Payments For Proceeds From Longterm Investments PaymentsForProceedsFromLongtermInvestments	-119000	USD
CY2013	us-gaap	Payments For Proceeds From Longterm Investments PaymentsForProceedsFromLongtermInvestments	-869000	USD
CY2015	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	10635000	USD
CY2014	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	6113000	USD
CY2013	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	1848000	USD
CY2015	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	634000	USD
CY2014	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	754000	USD
CY2013	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	529000	USD
CY2015	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	4903000	USD
CY2014	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	10851000	USD
CY2013	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	8534000	USD
CY2015	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	21537000	USD
CY2014	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	1983000	USD
CY2013	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-19799000	USD
CY2015	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	16914000	USD
CY2014	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	10644000	USD
CY2013	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	34106000	USD
CY2015	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	287000	USD
CY2014	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	1980000	USD
CY2013	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	2198000	USD
CY2015	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	17201000	USD
CY2014	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	12624000	USD
CY2013	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	36304000	USD
CY2015	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	18133000	USD
CY2014	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-4514000	USD
CY2013	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-382000	USD
CY2013Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9007000	USD
CY2012Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9389000	USD
CY2015	us-gaap	Income Taxes Paid IncomeTaxesPaid	54000	USD
CY2014	us-gaap	Income Taxes Paid IncomeTaxesPaid	48000	USD
CY2013	us-gaap	Income Taxes Paid IncomeTaxesPaid	18000	USD
CY2015	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	612000	USD
CY2014	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	243000	USD
CY2013	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	872000	USD
CY2015	us-gaap	Stock Issued1 StockIssued1	263000	USD
CY2014	us-gaap	Stock Issued1 StockIssued1		USD
CY2013	us-gaap	Stock Issued1 StockIssued1	1400000	USD
CY2015	us-gaap	Noncash Or Part Noncash Acquisition Investments Acquired1 NoncashOrPartNoncashAcquisitionInvestmentsAcquired1		USD
CY2014	us-gaap	Noncash Or Part Noncash Acquisition Investments Acquired1 NoncashOrPartNoncashAcquisitionInvestmentsAcquired1	10414000	USD
CY2013	us-gaap	Noncash Or Part Noncash Acquisition Investments Acquired1 NoncashOrPartNoncashAcquisitionInvestmentsAcquired1		USD
CY2015	us-gaap	Other Significant Noncash Transaction Value Of Consideration Given1 OtherSignificantNoncashTransactionValueOfConsiderationGiven1	790000	USD
CY2014	us-gaap	Other Significant Noncash Transaction Value Of Consideration Given1 OtherSignificantNoncashTransactionValueOfConsiderationGiven1		USD
CY2013	us-gaap	Other Significant Noncash Transaction Value Of Consideration Given1 OtherSignificantNoncashTransactionValueOfConsiderationGiven1		USD
CY2011Q3	us-gaap	Licenses Revenue LicensesRevenue	7000000	USD
CY2011Q3	us-gaap	Revenue From Grants RevenueFromGrants	5000000	USD
CY2011Q3	us-gaap	Proceeds From Customers ProceedsFromCustomers	2000000	USD
CY2015	psti	Research And Development Milestone Revenue Receivable ResearchAndDevelopmentMilestoneRevenueReceivable	37500000	USD
CY2015	us-gaap	Reimbursement Revenue ReimbursementRevenue	10000000	USD
CY2013Q4	us-gaap	Stock Issued During Period Shares Purchase Of Assets StockIssuedDuringPeriodSharesPurchaseOfAssets	2500000	shares
CY2015Q2	psti	Available For Sale Marketable Securities Number AvailableForSaleMarketableSecuritiesNumber	1011504	shares
CY2013Q4	us-gaap	Stock Issued During Period Value Purchase Of Assets StockIssuedDuringPeriodValuePurchaseOfAssets	10414000	USD
CY2015Q2	us-gaap	Available For Sale Securities AvailableForSaleSecurities	22250000	USD
CY2014Q2	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	27025000	USD
CY2015Q2	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	20156000	USD
CY2015Q2	us-gaap	Available For Sale Equity Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax	2255000	USD
CY2015Q2	us-gaap	Available For Sale Equity Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax	161000	USD
CY2014Q2	us-gaap	Available For Sale Equity Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax	2965000	USD
CY2014Q2	us-gaap	Available For Sale Equity Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax	29000	USD
CY2014Q2	us-gaap	Available For Sale Securities AvailableForSaleSecurities	29961000	USD
CY2015Q2	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	2535000	USD
CY2015Q2	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	107000	USD
CY2015Q2	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	524000	USD
CY2015Q2	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	54000	USD
CY2014Q2	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	851000	USD
CY2014Q2	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	17000	USD
CY2014Q2	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	463000	USD
CY2014Q2	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	12000	USD
CY2015Q2	us-gaap	Interest Receivable InterestReceivable	105000	USD
CY2014Q2	us-gaap	Interest Receivable InterestReceivable	98000	USD
CY2015Q2	us-gaap	Derivative Assets Liabilities At Fair Value Net DerivativeAssetsLiabilitiesAtFairValueNet	322000	USD
CY2014Q2	us-gaap	Derivative Assets Liabilities At Fair Value Net DerivativeAssetsLiabilitiesAtFairValueNet	-842000	USD
CY2015Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	16255000	USD
CY2014Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	14955000	USD
CY2015Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	6082000	USD
CY2014Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	4132000	USD
CY2015Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	395000	USD
CY2014Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	424000	USD
CY2015Q2	psti	Other Accounts Payable Payroll Institutions OtherAccountsPayablePayrollInstitutions	293000	USD
CY2014Q2	psti	Other Accounts Payable Payroll Institutions OtherAccountsPayablePayrollInstitutions	302000	USD
CY2015Q2	us-gaap	Accrued Vacation Current AccruedVacationCurrent	748000	USD
CY2014Q2	us-gaap	Accrued Vacation Current AccruedVacationCurrent	673000	USD
CY2015Q2	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent		USD
CY2014Q2	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	889000	USD
CY2015Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	97000	USD
CY2014Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	103000	USD
CY2015Q2	us-gaap	Pledged Assets Not Separately Reported Other Financial Instruments PledgedAssetsNotSeparatelyReportedOtherFinancialInstruments	1076000	USD
CY2015	psti	Percentage Of Qualified Expenditures PercentageOfQualifiedExpenditures	0.50	pure
CY2015	psti	Royalty Rate Payable On Grants Received RoyaltyRatePayableOnGrantsReceived	1.00	pure
CY2015Q2	psti	Aggregate Grants Received AggregateGrantsReceived	18642000	USD
CY2015Q2	psti	Royalties Amount Paid And Accrued RoyaltiesAmountPaidAndAccrued	66000	USD
CY2015Q2	us-gaap	Royalty Guarantees Commitments Amount RoyaltyGuaranteesCommitmentsAmount	18576000	USD
CY2015	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-1109000	USD
CY2014	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	407000	USD
CY2013	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	497000	USD
CY2015	psti	Interest On Short Term Bank Credit And Bank Expenses InterestOnShortTermBankCreditAndBankExpenses	37000	USD
CY2014	psti	Interest On Short Term Bank Credit And Bank Expenses InterestOnShortTermBankCreditAndBankExpenses	36000	USD
CY2013	psti	Interest On Short Term Bank Credit And Bank Expenses InterestOnShortTermBankCreditAndBankExpenses	29000	USD
CY2015	us-gaap	Interest Income Deposits With Financial Institutions InterestIncomeDepositsWithFinancialInstitutions	112000	USD
CY2014	us-gaap	Interest Income Deposits With Financial Institutions InterestIncomeDepositsWithFinancialInstitutions	246000	USD
CY2013	us-gaap	Interest Income Deposits With Financial Institutions InterestIncomeDepositsWithFinancialInstitutions	539000	USD
CY2015	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss	1229000	USD
CY2014	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss	384000	USD
CY2013	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss	-79000	USD
CY2015	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	395000	USD
CY2014	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-83000	USD
CY2013	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	140000	USD
CY2012Q3	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	8000000	shares
CY2012Q3	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	4.00
CY2012Q3	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	34106000	USD
CY2015Q2	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	14424883	shares
CY2015Q2	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	14423883	shares
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	1760768	shares
CY2015Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	17000000	USD
CY2015Q2	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	1200000	USD
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1862099	shares
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.73
CY2015	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	14000	shares
CY2015	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.77
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	11199	shares
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	7.79
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1836900	shares
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.72
CY2015	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y1M20D
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	768000	USD
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1836900	shares
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	3.72
CY2015	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P2Y1M20D
CY2015Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	768000	USD
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	1836900	shares
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	3.72
CY2015	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P2Y1M20D
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	768000	USD
CY2014Q2	psti	Sharebased Goods And Nonemployees Services Transaction Warrants And Options Number SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumber	252000	shares
CY2014Q2	psti	Warrants And Options Weighted Average Exercise Price WarrantsAndOptionsWeightedAverageExercisePrice	5.19
CY2015	psti	Sharebased Goods And Nonemployees Services Transaction Warrants And Options Granted SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsGranted	1000	shares
CY2015	psti	Warrants And Options Granted Weighted Average Exercise Price WarrantsAndOptionsGrantedWeightedAverageExercisePrice	0.00
CY2015	psti	Sharebased Goods And Nonemployees Services Transaction Warrants And Options Exercised SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsExercised	25000	shares
CY2015	psti	Warrants And Options Exercised Weighted Average Exercise Price WarrantsAndOptionsExercisedWeightedAverageExercisePrice	0.00
CY2015Q2	psti	Sharebased Goods And Nonemployees Services Transaction Warrants And Options Number SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumber	228000	shares
CY2015Q2	psti	Warrants And Options Weighted Average Exercise Price WarrantsAndOptionsWeightedAverageExercisePrice	5.73
CY2015	psti	Warrants And Options Weighted Average Remaining Contractual Term WarrantsAndOptionsWeightedAverageRemainingContractualTerm	P2Y10M13D
CY2015Q2	psti	Warrants And Options Aggregate Intrinsic Value WarrantsAndOptionsAggregateIntrinsicValue	204000	USD
CY2015Q2	psti	Sharebased Goods And Nonemployees Services Transaction Warrants And Options Number Exercisable SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumberExercisable	227000	shares
CY2015Q2	psti	Warrants And Options Weighted Average Exercise Price Excercisable WarrantsAndOptionsWeightedAverageExercisePriceExcercisable	5.76
CY2015	psti	Warrants And Options Weighted Average Remaining Contractual Term Exercisable WarrantsAndOptionsWeightedAverageRemainingContractualTermExercisable	P2Y10M2D
CY2015Q2	psti	Warrants And Options Aggregate Intrinsic Value Exercisable WarrantsAndOptionsAggregateIntrinsicValueExercisable	201000	USD
CY2015Q2	psti	Sharebased Goods And Nonemployees Services Transaction Warrants And Options Number Vested And Expected To Vest SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumberVestedAndExpectedToVest	1000	shares
CY2015Q2	psti	Warrants And Options Weighted Average Exercise Price Vested And Expected To Vest WarrantsAndOptionsWeightedAverageExercisePriceVestedAndExpectedToVest	0.00
CY2015	psti	Warrants And Options Weighted Average Remaining Contractual Term Vested And Expected To Vest WarrantsAndOptionsWeightedAverageRemainingContractualTermVestedAndExpectedToVest	P9Y6M11D
CY2015Q2	psti	Warrants And Options Aggregate Intrinsic Value Vested And Expected To Vest WarrantsAndOptionsAggregateIntrinsicValueVestedAndExpectedToVest	3000	USD
CY2015Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2015Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2015	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2015	dei	Document Type DocumentType	10-K
CY2014	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	2596032	shares
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	15193210	shares
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	1508579	shares
CY2015	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.00	pure
CY2014	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.00	pure
CY2013	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.00	pure
CY2015Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	9132000	USD
CY2014Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	7955000	USD
CY2015Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Foreign DeferredTaxAssetsOperatingLossCarryforwardsForeign	19880000	USD
CY2014Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Foreign DeferredTaxAssetsOperatingLossCarryforwardsForeign	12810000	USD
CY2015Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	226000	USD
CY2014Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	237000	USD
CY2015Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	29238000	USD
CY2014Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	21002000	USD
CY2015Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	29238000	USD
CY2014Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	21002000	USD
CY2015Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		USD
CY2014Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		USD
CY2014Q4	psti	Stock Issued During Period Shares Private Placement StockIssuedDuringPeriodSharesPrivatePlacement	200000	shares
CY2014Q4	psti	Stock Issued During Period Value Private Placement StockIssuedDuringPeriodValuePrivatePlacement	528000	USD
CY2015Q1	psti	Stock Issued During Period Shares Private Placement StockIssuedDuringPeriodSharesPrivatePlacement	200000	shares
CY2015Q1	psti	Stock Issued During Period Value Private Placement StockIssuedDuringPeriodValuePrivatePlacement	586000	USD
CY2015Q2	psti	Stock Issued During Period Shares Private Placement StockIssuedDuringPeriodSharesPrivatePlacement	300000	shares
CY2015Q2	psti	Stock Issued During Period Value Private Placement StockIssuedDuringPeriodValuePrivatePlacement	790000	USD
CY2015Q2	psti	Aggregate Offering Price Under Atm Agreement AggregateOfferingPriceUnderATMAgreement	95000000	USD
CY2015Q2	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	6800000	shares
CY2015Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	4080000	shares
CY2015Q2	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	2.50
CY2015Q1	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	100004	shares
CY2015Q2	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	90000	shares
CY2015Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	3300000	ILS
CY2015Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	841000	USD
CY2015Q2	us-gaap	Other Construction Costs OtherConstructionCosts	4000000	ILS
CY2015Q2	us-gaap	Other Construction Costs OtherConstructionCosts	1032000	USD
CY2015Q2	us-gaap	Construction In Progress Expenditures Incurred But Not Yet Paid ConstructionInProgressExpendituresIncurredButNotYetPaid	3000000	ILS
CY2015Q2	us-gaap	Construction In Progress Expenditures Incurred But Not Yet Paid ConstructionInProgressExpendituresIncurredButNotYetPaid	774000	USD
CY2015Q2	psti	Percentage Of Construction Milestones Completed PercentageOfConstructionMilestonesCompleted	0.55	pure
CY2015Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	79106381	shares
CY2015	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2015
CY2015	dei	Amendment Flag AmendmentFlag	false
CY2015	us-gaap	Share Based Goods And Nonemployee Services Transaction Capitalized Cost ShareBasedGoodsAndNonemployeeServicesTransactionCapitalizedCost	263000	USD
CY2015Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	5717000	USD
CY2015Q1	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	282000	USD
CY2015Q2	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	5982000	USD
CY2015	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
CY2015	dei	Document Period End Date DocumentPeriodEndDate	2015-06-30
CY2015	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2015	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2015	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2015	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2014Q4	dei	Entity Public Float EntityPublicFloat	164533166	USD
CY2015	dei	Entity Registrant Name EntityRegistrantName	PLURISTEM THERAPEUTICS INC
CY2015	dei	Entity Central Index Key EntityCentralIndexKey	0001158780
CY2015Q2	us-gaap	Value Added Tax Receivable Current ValueAddedTaxReceivableCurrent	152000	USD
CY2015Q2	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	621000	USD
CY2015Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	919000	USD
CY2014Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	382000	USD
CY2015Q2	psti	Accounts Receivable From Ministry Of Economy Current AccountsReceivableFromMinistryOfEconomyCurrent	44000	USD
CY2014Q2	psti	Accounts Receivable From Ministry Of Economy Current AccountsReceivableFromMinistryOfEconomyCurrent		USD
CY2015Q2	us-gaap	Cash Flow Hedges Derivative Instruments At Fair Value Net CashFlowHedgesDerivativeInstrumentsAtFairValueNet	52000	USD
CY2014Q2	us-gaap	Cash Flow Hedges Derivative Instruments At Fair Value Net CashFlowHedgesDerivativeInstrumentsAtFairValueNet	24000	USD
CY2015Q2	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Asset At Fair Value DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue	270000	USD
CY2014Q2	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Asset At Fair Value DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue	23000	USD
CY2014Q2	us-gaap	Value Added Tax Receivable Current ValueAddedTaxReceivableCurrent	459000	USD
CY2014Q2	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	17000	USD
CY2015	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax	262000	USD
CY2014	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax	-48000	USD
CY2013	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax		USD
CY2015	psti	Advance Payment For Deveploment Costs AdvancePaymentForDeveplomentCosts	2000000	USD
CY2015Q2	psti	Reclass From Research And Development Expense To Cost Of Revenues ReclassFromResearchAndDevelopmentExpenseToCostOfRevenues	1907000	USD
CY2015	us-gaap	Use Of Estimates UseOfEstimates	<div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <p style="line-height: 12pt; margin: 3pt 0pt 3pt 27pt; text-align: justify; text-indent: -27pt; font-family: 'times new roman';"><font style="font-family: 'Times New Roman'; font-size: 11pt;"><strong>a. </strong></font><font style="font-family: 'Times New Roman'; font-size: 11pt;"><strong>     </strong></font><font style="font-family: 'Times New Roman'; font-size: 11pt;"><strong>Use of estimates</strong></font></p> <p style="line-height: 12pt; margin: 3pt 0pt 3pt 27pt; text-align: justify; text-indent: -27pt; font-family: 'times new roman';"><font style="font-family: 'Times New Roman'; font-size: 11pt;">        </font><font style="font-family: 'Times New Roman'; font-size: 11pt;">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates, judgments, and assumptions that are reasonable based upon information availa</font><font style="font-family: 'Times New Roman'; font-size: 11pt;">ble at the time they are made. </font><font style="font-family: 'Times New Roman'; font-size: 11pt;">These estimates, judgments and assumptions can affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.</font></p> </div>
CY2015	us-gaap	Deferred Revenue Additions DeferredRevenueAdditions	5000000	USD
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	2.70
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	3.53
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	3.43
CY2015	us-gaap	Postemployment Benefits Period Expense PostemploymentBenefitsPeriodExpense	441000	USD
CY2014	us-gaap	Postemployment Benefits Period Expense PostemploymentBenefitsPeriodExpense	534000	USD
CY2013	us-gaap	Postemployment Benefits Period Expense PostemploymentBenefitsPeriodExpense	329000	USD
CY2015	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	248000	USD
CY2015	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <ol style="margin: 0pt; padding-left: 0pt;" start="16" type="a"> <li style="font-family: 'times new roman'; font-size: 11pt; list-style-position: inside; margin: 3pt 0pt 3pt 72pt; text-align: justify; text-indent: -72pt;"><strong><font style="font-family: 'Times New Roman';"></font><font style="font-family: 'Times New Roman'; font-size: 11pt; font-weight: bold;">      Concentration of credit risk  </font></strong></li> </ol> <p style="margin: 3pt 0pt 3pt 28.35pt; text-align: justify; text-indent: -1.35pt; font-family: 'times new roman';"><font style="font-family: 'Times New Roman'; font-size: 11pt;"> </font><font style="font-family: 'Times New Roman'; font-size: 11pt;">Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents, short-term deposits, long-term deposits</font><font style="font-family: 'Times New Roman'; font-size: 11pt;">,</font><font style="font-family: 'Times New Roman'; font-size: 11pt;"> restricted deposits</font><font style="font-family: 'Times New Roman'; font-size: 11pt;"> and marketable securities</font><font style="font-family: 'Times New Roman'; font-size: 11pt;">. </font></p> <p style="margin: 3pt 0pt 3pt 28.35pt; text-align: justify; text-indent: -1.35pt; font-family: 'times new roman';"><font style="font-family: 'Times New Roman'; font-size: 11pt;"> </font><font style="font-family: 'Times New Roman'; font-size: 11pt;">The majority of the Company's cash and cash equivalents and short-term and long-term deposits are invested in dollar instruments of major banks in Israel</font><font style="font-family: 'Times New Roman'; font-size: 11pt;"> and in the</font><font style="font-family: 'Times New Roman'; font-size: 11pt;"> United States</font><font style="font-family: 'Times New Roman'; font-size: 11pt;">. </font><font style="font-family: 'Times New Roman'; font-size: 11pt;">Generally, these deposits may be redeemed upon demand and therefore bear minimal risk. </font></p> <p style="margin: 6pt 0pt 0pt 27.35pt; text-align: justify; text-indent: -27pt; font-family: 'times new roman';"><font style="font-family: 'Times New Roman'; font-size: 11pt;">          </font><font style="font-family: 'Times New Roman'; font-size: 11pt;">The Company invests its surplus cash in cash deposits and marketable securities in financial institutions and has established guidelines</font><font style="font-family: 'Times New Roman'; font-size: 11pt;">, approved by the </font><font style="font-family: 'Times New Roman'; font-size: 11pt;">Company's Investment Committee</font><font style="font-family: 'Times New Roman'; font-size: 11pt;">,</font><font style="font-family: 'Times New Roman'; font-size: 11pt;"> relating to diversification and maturities to maintain safety and liquidity of the investments.</font></p> <p style="margin: 6pt 0pt 0pt 27.35pt; text-align: justify; text-indent: -27pt; font-family: 'times new roman';"><font style="font-family: 'Times New Roman'; font-size: 11pt;">          </font><font style="font-family: 'Times New Roman'; font-size: 11pt;">The Company holds an investment portfolio consisting of corporate bonds, </font><font style="font-family: 'Times New Roman'; font-size: 11pt;">g</font><font style="font-family: 'Times New Roman'; font-size: 11pt;">overnment </font><font style="font-family: 'Times New Roman'; font-size: 11pt;">bonds</font><font style="font-family: 'Times New Roman'; font-size: 11pt;">, stocks and </font><font style="font-family: 'Times New Roman'; font-size: 11pt;">index linked notes</font><font style="font-family: 'Times New Roman'; font-size: 11pt;">. The Company intends, and has the ability, to hold such investments until recovery of temporary declines in market value or maturity; accordingly, as of </font><font style="font-family: 'Times New Roman'; font-size: 11pt;">June 30, 2015</font><font style="font-family: 'Times New Roman'; font-size: 11pt;">, the Company believes the losses associated with its investments are temporary and <font>no</font> impairment loss was recognized during </font><font style="font-family: 'Times New Roman'; font-size: 11pt;">2015</font><font style="font-family: 'Times New Roman'; font-size: 11pt;">. However, the Company can provide no assurance that it will recover declines in the market value of its investments.</font></p> </div>
CY2014	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	-70000	USD
CY2013	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	231000	USD
CY2015	psti	Remaining Deferred Revenue Recognition Period For Intangible Asset RemainingDeferredRevenueRecognitionPeriodForIntangibleAsset	P7Y6M
CY2015	psti	Business Combination Contingent Consideration Receivable Upon Certain Regulatory Milestones BusinessCombinationContingentConsiderationReceivableUponCertainRegulatoryMilestones	37500000	USD
CY2015	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	-1109000	USD
CY2015	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	-290000	USD

Files In Submission

Name	View Source	Status
0001178913-15-002818-index-headers.html	Edgar Link	pending
0001178913-15-002818-index.html	Edgar Link	pending
0001178913-15-002818.txt	Edgar Link	pending
0001178913-15-002818-xbrl.zip	Edgar Link	pending
exhibit_10-32.htm	Edgar Link	pending
exhibit_23-1.htm	Edgar Link	pending
exhibit_31-1.htm	Edgar Link	pending
exhibit_31-2.htm	Edgar Link	pending
exhibit_32-1.htm	Edgar Link	pending
exhibit_32-2.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
img1.jpg	Edgar Link	pending
logo.jpg	Edgar Link	pending
psti-20150630.xml	Edgar Link	completed
psti-20150630.xsd	Edgar Link	pending
psti-20150630_cal.xml	Edgar Link	unprocessable
psti-20150630_def.xml	Edgar Link	unprocessable
psti-20150630_lab.xml	Edgar Link	unprocessable
psti-20150630_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
zk1517290.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PLUR
Pluri Inc. Stock $plur

2015 Q3 Form 10-K Financial Statement

#000117891315002818 Filed on September 09, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PLUR Pluri Inc. Stock $plur

2015 Q3 Form 10-K Financial Statement

#000117891315002818 Filed on September 09, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PLUR
Pluri Inc. Stock $plur